Posts by Franny White

Antibody research driven by need for better HIV treatment

Ann Hessell, Ph.D., modifies lab-made antibodies to aid HIV fight. Although antibodies are commonly discussed by the general public right now due to the COVID-19 pandemic, many scientists have...

Mark Pennesi, M.D., Ph.D., center right, and staff at OHSU's Casey Eye Institute perform the first-ever in vivo CRISPR gene edit procedure for the BRILLIANCE clinical trial.

OHSU Casey Eye Institute grows gene and cell therapy research by performing its first stem cell therapy in the retina

The OHSU Casey Eye Institute has used a stem cell therapy in the retina for the first time as part of a Phase 2a clinical trial evaluating the safety and efficacy of an experimental treatment for an...

COVID-19 clinical data available for research through new N3C analytics platform

OHSU researchers seeking to advance COVID-19 science encouraged to request data access OHSU researchers studying COVID-19 are encouraged to access data from the records of more than 50,000...

Yali Jia receives 2019 ARVO award for translational eye research

Yali Jia, Ph.D., codeveloped an algorithm that enables a highly efficient, non-invasive eye imaging technology called optical coherence tomographic angiography, or OCTA. In recognition of this and...